Newcastle Disease, Infectious Bronchitis and Avian Influenza (H9 Subtype) Vaccine, Inactivated
- Indication / Application: Used for preventing Newcastle Disease, Infectious Bronchitis and Avian Influenza (subtype H9) in chickens.
- Manufacturing: Produced in GMP-certified facility
- Supply Mode: Bulk Supply / Distributor / OEM Available
- Origin: China
Generic Name
Newcastle Disease, Infectious Bronchitis and Avian Influenza (H9 Subtype) Vaccine, Inactivated
Composition and Content
| Disease | Strain | Antigen Content | Optional Strain(s) |
|---|---|---|---|
| ND | La Sota | ≥ 108.5 EID50/0.1ml | La Sota + A-VII; Clone30 |
| IB | M41 | ≥ 106.5 EID50/0.1ml | QX; M41 + QX |
| AI(H9N2) | Clade 9.4.2.5 | ≥ 108.5 EID50/0.1ml | H9 (9.4.1a); H9 (9.4.1b) |
Indications
For the prevention of Newcastle disease (La Sota strain), infectious bronchitis (M41 strain), avian influenza (H9N2 subtype, clade 9.4.2.5), and infectious coryza (serotypes A, B, and C). Immunity develops 14-21 days after vaccination and lasts for 6 months.
Dosage and Administration
Administer subcutaneously in the neck or intramuscularly: 0.3 mL per bird for chickens under 4 weeks of age; 0.5 mL per bird for chickens over 4 weeks of age.
Adverse Reactions
Generally, no obvious adverse reactions occur after vaccination. Feed intake may decrease in individual birds for 1-2 days, and egg production may be slightly affected in layers; recovery occurs within a few days.
Specification
250 mL/bottle; 500 mL/bottle.
Storage and Shelf Life
Store at 2-8°C. Shelf life: 24 months.
Appearance
A uniform milky-white emulsion.
Precautions
- 1. Vaccinate healthy chickens only. Do not use in emaciated or sick chickens.
- 2. Before use, check for a damaged vial, missing label, foreign matter, or severe oil-water separation. Do not use if any abnormality is found.
- 3. Allow the vaccine to reach room temperature and shake thoroughly before use.
- 4. Use within 2 hours after first opening and prevent contamination.
- 5. This vaccine may be used with live Newcastle disease and infectious bronchitis vaccines to enhance cellular and mucosal immunity.